AI
AZN icon

Atom Investors’s AstraZeneca AZN Stock Holding History

Atom Investors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,760
Closed -$3.04M – 604
2025
Q2 		$3.04M Buy
+21,760
New +$3.05M 0.27% 104
2024
Q2 		– Sell
-34,638
Closed -$4.69M – 489
2024
Q1 		$4.69M Buy
+34,638
New +$4.59M 0.59% 41

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Atom Investors's AZN Position: Q3 2025 in Review

Atom Investors sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 21,760 shares — an estimated $3.04M sold.

Atom Investors first reported a position in AZN in Q1 2024 and held it in 2 quarters. The position peaked at $4.69M in Q1 2024. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Atom Investors reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
  • Atom Investors sold 21,760 AstraZeneca shares in Q3 2025, an estimated $3.04M.
  • Atom Investors first reported a position in AstraZeneca in Q1 2024 and held it in 2 quarters.
  • Atom Investors's AstraZeneca position peaked at $4.69M in Q1 2024.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.